- Home
- ALDX vs CHN Comparison
ALDX vs CHN Comparison
Compare ALDX & CHN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALDX
- CHN
- Stock Information
- Founded
- ALDX 2004
- CHN 1992
- Country
- ALDX United States
- CHN United States
- Employees
- ALDX N/A
- CHN N/A
- Industry
- ALDX Biotechnology: Pharmaceutical Preparations
- CHN Investment Managers
- Sector
- ALDX Health Care
- CHN Finance
- Exchange
- ALDX Nasdaq
- CHN Nasdaq
- Market Cap
- ALDX 160.8M
- CHN 144.1M
- IPO Year
- ALDX 2014
- CHN N/A
- Fundamental
- Price
- ALDX $4.76
- CHN $14.97
- Analyst Decision
- ALDX Strong Buy
- CHN
- Analyst Count
- ALDX 2
- CHN 0
- Target Price
- ALDX $9.50
- CHN N/A
- AVG Volume (30 Days)
- ALDX 1.2M
- CHN 31.8K
- Earning Date
- ALDX 07-31-2025
- CHN 01-01-0001
- Dividend Yield
- ALDX N/A
- CHN 0.19%
- EPS Growth
- ALDX N/A
- CHN N/A
- EPS
- ALDX N/A
- CHN N/A
- Revenue
- ALDX N/A
- CHN N/A
- Revenue This Year
- ALDX N/A
- CHN N/A
- Revenue Next Year
- ALDX N/A
- CHN N/A
- P/E Ratio
- ALDX N/A
- CHN N/A
- Revenue Growth
- ALDX N/A
- CHN N/A
- 52 Week Low
- ALDX $1.14
- CHN $9.00
- 52 Week High
- ALDX $7.20
- CHN $12.98
- Technical
- Relative Strength Index (RSI)
- ALDX 78.74
- CHN 74.35
- Support Level
- ALDX $4.12
- CHN $14.69
- Resistance Level
- ALDX $4.60
- CHN $14.88
- Average True Range (ATR)
- ALDX 0.29
- CHN 0.21
- MACD
- ALDX 0.08
- CHN 0.00
- Stochastic Oscillator
- ALDX 90.91
- CHN 96.30
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
About CHN China Fund Inc. (The)
CHINA FUND INC is a non-diversified, closed-end management investment company. Its investment objective is a long-term capital appreciation which it seeks to achieve by investing in equity securities with trading in China and outside China. It invests in various industries such as Insurance, Entertainment, Machinery, Electrical Equipment, Beverages, Hotels, Restaurants, and Leisure among others.